Boston, MA -- (SBWIRE) -- 08/11/2015 -- Healthcare expenditure in Pakistan will grow strongly, albeit from a low base. Central to this trajectory is the rise in household incomes as out-of-pocket health spending remains a dominant source of healthcare financing. This is further supported by the higher health expenditure by administrative unit authorities which have outlined long-term medical strategies. At the sub-national level, the strongest commercial prospects for pharmaceutical and medical device companies will be in the more economically developed provinces of Punjab and Sindh.

Get More Details on this Report and a Full Table of Contents at Pakistan Pharmaceuticals & Healthcare Report Q4 2015

Headline Expenditure Projections

- Pharmaceuticals: PKR231.2bn (USD2.29bn) in 2014 to PRK252bn (USD2.45bn) 2015; +9.2%in local currency terms and +7.1% in US dollar terms.

- Healthcare: PKR685bn (USD6.8bn) in 2014 to PKR758bn (USD7.36n) in 2015; +10.7% in local currency terms and +8.6% in US dollar terms.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 800-844-8156 (413-485-7001 Int'l)